Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
Nautilus Biotechnology Inc (NASDAQ: NAUT) closed the day trading at $0.96 down -9.43% from the previous closing price of $1.06. In other words, the price has decreased by -$9.43 from its previous closing price. On the day, 0.55 million shares were traded. NAUT stock price reached its highest trading level at $1.1 during the session, while it also had its lowest trading level at $0.9434.
Ratios:
For a better understanding of NAUT, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 17.40 and its Current Ratio is at 17.40. In the meantime, Its Debt-to-Equity ratio is 0.15 whereas as Long-Term Debt/Eq ratio is at 0.13.
On June 27, 2024, Guggenheim started tracking the stock assigning a Buy rating and target price of $6.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 17 ’24 when MARY GODWIN bought 38,337 shares for $1.94 per share.
MARY GODWIN bought 35,000 shares of NAUT for $74,588 on Dec 09 ’24. On Dec 03 ’24, another insider, MARY GODWIN, who serves as the Officer of the company, bought 60,000 shares for $2.20 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NAUT now has a Market Capitalization of 121102080 and an Enterprise Value of 21687530.
Stock Price History:
The Beta on a monthly basis for NAUT is 1.12, which has changed by -0.6521739 over the last 52 weeks, in comparison to a change of 0.08275449 over the same period for the S&P500. Over the past 52 weeks, NAUT has reached a high of $3.09, while it has fallen to a 52-week low of $1.05. The 50-Day Moving Average of the stock is -38.71%, while the 200-Day Moving Average is calculated to be -57.41%.
Shares Statistics:
Over the past 3-months, NAUT traded about 127.36K shares per day on average, while over the past 10 days, NAUT traded about 132810 shares per day. A total of 126.11M shares are outstanding, with a floating share count of 58.00M. Insiders hold about 54.02% of the company’s shares, while institutions hold 29.18% stake in the company. Shares short for NAUT as of 1740700800 were 291638 with a Short Ratio of 2.29, compared to 1738281600 on 272034. Therefore, it implies a Short% of Shares Outstanding of 291638 and a Short% of Float of 0.69.
Earnings Estimates
Investors are keenly observing as 2.0 analysts analyze and rate the current performance of Nautilus Biotechnology Inc (NAUT) in the stock market.The consensus estimate for the next quarter is -$0.14, with high estimates of -$0.13 and low estimates of -$0.14.
Analysts are recommending an EPS of between -$0.55 and -$0.57 for the fiscal current year, implying an average EPS of -$0.56. EPS for the following year is -$0.76, with 2.0 analysts recommending between -$0.69 and -$0.84.
